Sunday, March 1, 2015

US priority review for B-MS' Opdivo in lung cancer

… for advanced squamous non-small cell lung cancer (NSCLC) after prior therapy.   The …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)